Screener
Arcus Biosciences RCUS Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's enterprise value?
- Arcus Biosciences (RCUS) reported enterprise value of $3.84B in Q2 2026.
- How has Arcus Biosciences's enterprise value changed year-over-year?
- Arcus Biosciences's enterprise value increased by 387.8% year-over-year, from $787.49M to $3.84B.
- What is the long-term trend for Arcus Biosciences's enterprise value?
- Over 5 years (2020 to 2025), Arcus Biosciences's enterprise value has grown at a 11.9% compound annual growth rate (CAGR), from $1.67B to $2.92B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Arcus Biosciences's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude